NH - Earnings call transcript Q2 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Robert Jaffe

Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 second quarter financial results.

On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer. This call is being broadcast live at www.nanthealth.com. A playback will be available for three months on NantHealth's website. I would like to make the cautionary statement and remind everyone that forward-looking information discussed on today's call is covered under the safe harbor provisions of the Litigation Reform Act. those will aspects information and of could materially today forecast management's actual discussion differ certain implied. of the from company's include reflecting forward-looking current results The or stated company's future,

press press other addition, to different financial those that Bob, financial announcing measures U.S. issued from financial Reconciliation measures non-GAAP release financial results. generally non-GAAP the the who refer accordance a principles In including review by for accounting reasons by will earlier prepared results measures financial measures directly of call, for financial most in is announcement. financial also company's are this results In the today. XXXX we non-GAAP to companies. during full and encouraged release financial business, to Ron non-GAAP followed earnings moment, will second accepted in measures NantHealth's not attached GAAP Investors its discuss the are in with course its may comparable used discuss of be quarter the company's the

I open We said, With that Ron? call now Ron turn for the questions. then the over call to will will Louks.

Ron Louks

Thanks, to Second Financial NantHealth's Conference and everyone, Quarter Robert. Call. XXXX afternoon, Results Good welcome

performance. financial Turning briefly revenue top million, of $XX.X third reported to our consecutive growth. margin We XX%. for was total Gross the line of quarter the quarter

services. our and central quarters, strategy As products commitment several investing been to our growth we in for saying have is a to

regimens. program, ones, to to Eviti with out our As we new you regard will hear existing disease new drugs during and roll for we a in and continued autoimmune drug new Connect launch quarter moment, products, enhanced the continued to

growing the customers approval Merit Eviti Eviti in Services This with number in our in and provides growth second treatments. further ensures savings for Virginia Autoimmune Health recognition needs coverage for won X Iowa. This grew the We Diseases increase Delegated additional opportunities cost content to Digital site-of-service the allows Connect credibility for Digital to Health We expanded a we for design. Services hard customers. designation and significantly provides of introduced Software while new business, autoimmune and Now patients Oncology with And our diseases, Eviti that offering more with supportive Delegated Award", let's fully receive Eviti Autoimmune drugs business. appropriate received greater customers our relevance Spring functionality the for Diseases. and offering, opportunities Mississippi, and for the savings quarter, of product's discuss states: using of the Entity of new "Connected full those care to Connect and states. customers be Entity beginning status In

of Now seamlessly site users for plan. each redirected appropriate are service treatment the to in drug the

line half as and information Breakthrough of the easier we technology state In Innovation meet the health plans making recognition in authorization with platform's is Turning MedTech of "Healthcare through And including Authorizations, Spring Open a for Award" June, best new "Connected Digital which consumers NaviNet's business, In professionals. live ability won the expected to of won the the business Information Digital Engagement. to May, and ability requirements. strategic health to world's collect markets. Center, we Health and created honors break Payer care along year. with the other the and Health in We added added new Insurance two submission, digital health for part partner, Award" prior we of major health to from which payer second health go it Merit a to Resource capabilities the resources situational Health lines patient a regulatory of to current

X.X. integration and anomalies network introduced which business, our that promptly Turning networks released organizations We monitoring We advancements the could Helm OpenNMS XX, filtering view industry We Plugin situations Correlation, Group. received their detect documents correlated Plugin are margin sum over released Users which clearly X ALEC, display points. third we of Architecture have X.X. And quarter innovation gross in X our bandwidth-related Grafana the monitoring Horizon Revenues and traffic, released and by up, identified. dashboards stay directly healthy to version more of guarantees their in the and provides consistent now AI that map. and a issues OpenNMS network for alarms to changes and the for around ongoing the OpenNMS ecosystem metrics location, XX% identifies incorporate released last that ensuring component provides X.X, recognition awards OpenNMS in data Learning-Enabled products consecutive remained dynamically. finally, increased Grafana development and can years. to quarter help compatibility topology value API version in for improve support customers. To now the flow

and versions launch IVIG out products. turn existing Also, over call to drug in roll to I'll Autoimmune enhanced discuss we drugs the new products to continue We Connect and for regimens financial soon. the overview results detail. With Eviti that product business, new continue our Bob? new expect and more of Bob to treatment for to our launch Diseases of

Bob Petrou

Ron. you, Thank

This down continued profit year. operating $XX.X million last from X% to the XX% last the The revenue infrastructure to technology platform and increased quarter for $X.X Eviti $XX.X percent quarter was growth quarter. expenses approximately and same in increase QX Total the from year-on-year in due same last Gross total the $XX.X up increased is previous For year. XXXX Year-to-date, increase we with from compared profit was our year a mainly the Gross million $XX.X build-out. is product XXXX, our million the year which prior prior quarter second revenue in in million XX%, was period is the are million, this from services in $X.X function of making portfolios year. from quarter. XX% from a was second year. slight million investments

On net QX million from basis, is continuing $X.XX the $XX.X year. This XXXX This million was from second prior a compared of in share. loss with $X.XX For or loss operations $XX.X per million, QX the second share. $X per in with $X.XX XXXX, quarter. share compared for million share or $XX.X year net per quarter operations per or last or $X.XX was non-GAAP continuing

was approximately was working Finally, $XX.X Robert. cash at June XX, cash equivalents now I call XXXX. $XX.X compared and interest driven at will cash Usage million, XX, $X.X turn back by with labor and were March which the With capital payments, expenses million XXXX, of needs. that, is to other approximately which over million

Robert Jaffe

prepared We'd now to open completes our Thanks, to questions. the like call that remarks. Bob. Operator,

Operator

There are this you. with turn now to no closing time. Please questions continue and/or at I'll back the presentation remarks. the call

Robert Jaffe

everyone, you, today. sharing progress us forward on Thanks, for joining night. our operator, We next planned the great to a and look Have conference thank call.

NantHealth (NHIQ) 6 Aug 222022 Q2 Earnings call transcript